Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000454448 | SCV000540228 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586911 | SCV000699748 | benign | not provided | 2017-07-10 | criteria provided, single submitter | clinical testing | Variant summary: The c.2616T>C (p.Pro872=) in RTEL1 gene is a synonymous change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this does not affect a normal splicing pattern, however no functional studies supporting these predictions were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.7653 20201/26266 chrs tested), including numerous homozygous occurrences. This frequency exceeds the estimated maximum allele frequency for a pathogenic allele in this gene (0.0011). In addition, the variant is cited as Benign/Polymorphism by a reputable database/clinical laboratory. Taking together, based on the prevalence of this variant in general population the variant was classified as Benign. |
Labcorp Genetics |
RCV001523488 | SCV001733198 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543251 | SCV001761778 | benign | Dyskeratosis congenita, autosomal recessive 5 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543252 | SCV001761779 | benign | Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000586911 | SCV001934844 | benign | not provided | 2018-11-28 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000454448 | SCV004232950 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied by a panel of primary immunodeficiencies. Number of patients: 85. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000586911 | SCV005314079 | benign | not provided | criteria provided, single submitter | not provided | ||
ARUP Laboratories, |
RCV000586911 | SCV005876226 | benign | not provided | 2024-11-27 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001272653 | SCV001454892 | benign | Dyskeratosis congenita | 2020-09-16 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000454448 | SCV001952343 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000454448 | SCV001972888 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome |
RCV000586911 | SCV002074742 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. |